Study period | |||||||
---|---|---|---|---|---|---|---|
Screening | Allocation | Post-allocation | |||||
Pregnancy | Pregnancy | Postpartum | |||||
Timepoint** | T-1 | 0 | T0 | T1 | T2 | T3 | T5 |
Eligibility screen | X | ||||||
Informed consent | X | X | X | X | X | X | |
Randomization | X | ||||||
Interventions: | |||||||
X | X | X | X | ||||
Telemental low-intensity psychosocial interventions A | |||||||
Control Group B | X | X | X | X | |||
Assessments: | |||||||
1. Mental health history | X | ||||||
2. Medication use | X | ||||||
3. COVID-19 status | X | X | X | X | X | ||
4. Perinatal depression | X | X | X | X | X | ||
5. COVID-19-specific phobia | X | X | X | X | X | ||
6. Perinatal anxiety | X | X | X | X | X | ||
7. Sociodemographic characteristics | X | X | X | X | X | ||
8. Pregnancy-related factors | X | X | |||||
9. Acute medical problem | X | X | X | X | X | ||
10. Previous maternal and neonatal complication | X | X | |||||
11. Chronic illnesses | X | X | |||||
12. Behavioral factors | X | X | X | X | X | ||
13. Stressful life events | X | X | X | X | X | ||
14. Newborn health | X | X | X |